Report Detail
Global (United States, European Union and China) Meningococcal Disease Drugs Market Research Report 2019-2025
- RnM3578899 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant risk of death associated with infection. Infection of Neisseria meningitidis may also result in mental retardation, deafness and epilepsy. 12 strains of N. meningitidis have been identified, 6 of which (A, B, C, W, X and Y) are capable enough to cause epidemics. Meningococcal septicaemia is a rare but fatal form of meningococcal disease characterized by a haemorrhagic rash and rapid circulatory collapse.
In 2019, the market size of Meningococcal Disease Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Meningococcal Disease Drugs.
This report studies the global market size of Meningococcal Disease Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Meningococcal Disease Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
GlaxoSmithKline
Sanofi Pasteur
Novartis
...
Market Segment by Product Type
Injectable
Oral
Market Segment by Application
Hospitals
Drugstores
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Meningococcal Disease Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Meningococcal Disease Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Meningococcal Disease Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Meningococcal Disease Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Injectable
- 1.3.3 Oral
- 1.4 Market Segment by Application
- 1.4.1 Global Meningococcal Disease Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Drugstores
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Meningococcal Disease Drugs Market Size
- 2.1.1 Global Meningococcal Disease Drugs Revenue 2014-2025
- 2.1.2 Global Meningococcal Disease Drugs Sales 2014-2025
- 2.2 Meningococcal Disease Drugs Growth Rate by Regions
- 2.2.1 Global Meningococcal Disease Drugs Sales by Regions 2014-2019
- 2.2.2 Global Meningococcal Disease Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Meningococcal Disease Drugs Sales by Manufacturers
- 3.1.1 Meningococcal Disease Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Meningococcal Disease Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Meningococcal Disease Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Meningococcal Disease Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Meningococcal Disease Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Meningococcal Disease Drugs Price by Manufacturers
- 3.4 Key Manufacturers Meningococcal Disease Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Meningococcal Disease Drugs Market
- 3.6 Key Manufacturers Meningococcal Disease Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Injectable Sales and Revenue (2014-2019)
- 4.1.2 Oral Sales and Revenue (2014-2019)
- 4.2 Global Meningococcal Disease Drugs Sales Market Share by Type
- 4.3 Global Meningococcal Disease Drugs Revenue Market Share by Type
- 4.4 Meningococcal Disease Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Meningococcal Disease Drugs Sales by Application
6 United States
- 6.1 United States Meningococcal Disease Drugs Breakdown Data by Company
- 6.2 United States Meningococcal Disease Drugs Breakdown Data by Type
- 6.3 United States Meningococcal Disease Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Meningococcal Disease Drugs Breakdown Data by Company
- 7.2 European Union Meningococcal Disease Drugs Breakdown Data by Type
- 7.3 European Union Meningococcal Disease Drugs Breakdown Data by Application
8 China
- 8.1 China Meningococcal Disease Drugs Breakdown Data by Company
- 8.2 China Meningococcal Disease Drugs Breakdown Data by Type
- 8.3 China Meningococcal Disease Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Meningococcal Disease Drugs Breakdown Data by Company
- 9.2 Rest of World Meningococcal Disease Drugs Breakdown Data by Type
- 9.3 Rest of World Meningococcal Disease Drugs Breakdown Data by Application
- 9.4 Rest of World Meningococcal Disease Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Meningococcal Disease Drugs Sales by Countries
- 9.4.2 Rest of World Meningococcal Disease Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Meningococcal Disease Drugs
- 10.1.4 Meningococcal Disease Drugs Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 GlaxoSmithKline
- 10.2.1 GlaxoSmithKline Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Meningococcal Disease Drugs
- 10.2.4 Meningococcal Disease Drugs Product Introduction
- 10.2.5 GlaxoSmithKline Recent Development
- 10.3 Sanofi Pasteur
- 10.3.1 Sanofi Pasteur Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Meningococcal Disease Drugs
- 10.3.4 Meningococcal Disease Drugs Product Introduction
- 10.3.5 Sanofi Pasteur Recent Development
- 10.4 Novartis
- 10.4.1 Novartis Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Meningococcal Disease Drugs
- 10.4.4 Meningococcal Disease Drugs Product Introduction
- 10.4.5 Novartis Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Meningococcal Disease Drugs Sales Channels
- 11.2.2 Meningococcal Disease Drugs Distributors
- 11.3 Meningococcal Disease Drugs Customers
12 Market Forecast
- 12.1 Global Meningococcal Disease Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Meningococcal Disease Drugs Sales Forecast by Type
- 12.3 Global Meningococcal Disease Drugs Sales Forecast by Application
- 12.4 Meningococcal Disease Drugs Forecast by Regions
- 12.4.1 Global Meningococcal Disease Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Meningococcal Disease Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Meningococcal Disease Drugs. Industry analysis & Market Report on Meningococcal Disease Drugs is a syndicated market report, published as Global (United States, European Union and China) Meningococcal Disease Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Meningococcal Disease Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
